Email this article 
Activity of Antimycobacterial Candidate from Bacteriocins and Lactic Acid Isolated from Lactobacillus bulgaricus Against Mycobacterium tuberculosis
Abstract
Mycobacterium tuberculosis (Mtb) is a bacterium that causes a respiratory infectious disease known as tuberculosis. Tuberculosis (TB) is a global infectious disease that causes death. The current TB treatment method has a weakness, namely the tendency of patients to disobey the rules in taking drugs because they have to take several tablets of medicine for a long time. As a result, some strains of M.tuberculosis can strengthen themselves and become resistant to antimycobacterial drugs used during therapy. Based on these tuberculosis control problems, the WHO declared a global TB emergency. The low effectiveness of currently used antitubercular drugs encourages the development of new antimycobacterial drugs with low side effects, fast-acting, broadly targeted, and can damage the virulence properties of M.tuberculosis so that the immune system can phagocytose M.tuberculosis. A recent solution from some researchers is to induce immunomodulatory effects that help during the tuberculosis infection process, including from lactic acid bacteria (LAB). This encourages researchers to reveal the interaction of probiotic L.bulgaricus on reducing the growth of M.tuberculosis by finding the main substance with antitubercular activity to obtain optimal results. This study used sensitive M.tuberculosis strain H37Rv to get complete preliminary data. This study tested lactic acid and bacteriocin of Lactobacillus bulgaricus at concentrations of 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% and 100%. M.tuberculosis bacteria were inoculated on media containing lactic acid and L. bulgaricus ATCC 11842 bacteriocin, then incubated at 37°C and observed every week from the fourth to the eighth week. Of the five concentrations of lactic acid and bacteriocin tested, only the 60-100% concentration could inhibit the growth of M.tuberculosis. In conclusion, lactic acid and bacteriocin of L. bulgaricus can hinder the growth of M.tuberculosis and can be developed into antimycobacterial drug candidates.
Keywords
Full Text:
PDFReferences
AlSahafi, A.J., Shah, H.B.U., AlSayali, M.M., Mandoura, N., Assiri, M., Almohammadi, E.L., et al. (2019). High Compliance Rate with Anti-Tuberculosis Treatment: A Need to Shift Facility-Based Directly Observed Therapy Short Course (DOTS) to Community Mobile Outreach Team Supervision in Saudi Arabia. BMC Public Health 19(1):1168. https://doi.org/10.1186/s12889-019-7520-8.
Cheruvari, A., Kammara, R. (2025). Bacteriocins future perspectives: Substitutes to antibiotics. Food Control Vol.168. https://doi.org/10.1016/j.foodcont.2024.110834.
Fauziah, P.N., Nurhajati J. and Chrysanti. (2014). Daya antibakteri filtrat asam laktat dan bakteriosin Lactobacillus bulgaricus KS1 dalam menghambat pertumbuhan Klebsiella pneumoniae strain ATCC 700603, CT1538, dan S941. Bandung Medical Journal 47(1):35-41. DOI: 10.15395/ mkb.v47n1.395.
Fauziah, P.N., Chrysanti, Sayuti, J.N. (2018). Effects of Lactobacillus bulgaricus in soyghurt on inhibition of adhesion Klebsiella pneumoniae strains in HEp-2 cell lines. International Food Research Journal 25(4):1720-1725. http://www.ifrj.upm.edu.my/25%20(04)%202018/(53).pdf.
Gupta, V.K., Kumar, M.M., Deepa, B., Anupam, K. (2017). Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met. Pharmaceutical Biology 55(1). https://doi.org/10.1080/13880209.2017.1309440.
Herawati, I., Hilmi, D., Prima, N.F. (2014). Effect of lactic acid filtrate and bacteriocins of lactobacillus acidophillus on phagocytosis activity of macrophages cell against enteropathogen Escherichia coli (EPEC). Microbiology Indonesia. DOI: 10.5454/mi.8.4.6.
Horvath A, Leber B, Schmerboeck B, Tawdrous M, Zettel G, Hartl A, et al. (2016). Randomized Clinical Trial: The Effects of a Multispecies Probiotic vs. Placebo on Innate Immune Function, Bacterial Translocation and Gut Permeability in Patients with Cirrhosis. Alimentary Pharmacology & Therapeutics. 44(9):926-35. https://doi.org/10.1111/apt.13788.
Irianti T, Pratiwi SUT, Intan FY. (2022). Antituberculosis Activity of Active Compound of Ethyl Acetate Extract for Patikan Kebo (Euphorbia hirta L.). Jordan Journal of Pharmaceutical Sciences. ;15(4):1-13. https://doi.org/10.35516/jjps.v15i4.671.
J.D. Simmons, C.M. Stein, C.M., C. Seshadri, C., Campo, M., Alter, G., Fortune, S., et al. (2018). Immunological Mechanisms of Human Resistance to Persistent Mycobacterium tuberculosis Infection. Nature Reviews Immunology 18(9):575-89. https://doi.org/10.1038/s41577-018-0025-3.
Joshi, T.J., Salini, S.V., Lakshmi, M., P. Nandagopal., Jobil, J.A. (2024). Functional metabolites of probiotic lactic acid bacteria in fermented dairy products. Food and Humanity Vol.3. http://dx.doi.org/10.1016/j.foohum.2024.100341.
Ma, Y., Yang, X., Chatterjee, V., Wu, M., Yuan, S.Y. (2020). The Gut-Lung Axis in Systemic Inflammation: Role of Mesenteric Lymph as Conduit. American Journal of Respiratory Cell and Molecular Biology. 64(1):19-28. https://doi.org/10.1165/rcmb.2020-0196tr.
McAleer, J.P., Kolls, J.K. (2018). Contributions of the Intestinal Microbiome in Lung Immunity. European Journal of Immunology 48(1):39-49. https://doi.org/10.1002/eji.201646721.
Ministry of Health Republic of Indonesia. (2022). Infodatin Tuberculosis. Ministry of Health RI. Jakarta.
Mishra, A., Singh, V.K., Jeffrey, K.A., Robert, L.H., Chinnaswamy, J., et al. (2020). GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to Tuberculosis Immunity?. Front Immunol Vol.11. https://doi.org/10.3389/fimmu.2020.01599.
Nkot, J.L., Bikobo, D.S.N., Auguste, A.A.Z., Norbert, M.N.II., Esther, D.F.M.N. (2018). Antitubercular evaluation of root extract and isolated phytochemicals from Lophira lanceolata against two resistant strains of Mycobacterium tuberculosis. Pharmaceutical Biology 56(1). https://doi.org/10.1080/13880209.2018.1476559.
Nurkanto, A., Masrukhin, Joseph, C.E.T., Muhammad, F.E., Ade, L.P., et al. (2024). Exploring Indonesian actinomycete extracts for anti-tubercular compounds: Integrating inhibition assessment, genomic analysis, and prediction of its target by molecular docking. Heliyon 10;e35648. https://doi.org/10.1016/j.heliyon.2024.e35648.
Rothchild, A.C., Stowell, B., Goyal, G., Nunes-Alves, C., Yang, Q., Papavinasasundaram, K., et al. (2017). Role of Granulocyte-Macrophage Colony-Stimulating Factor Production by T Cells during Mycobacterium tuberculosis Infection. MBio 8(5). https://doi.org/10.1128/mBio.01514-17.
Smith, I. (2003). Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence. J. Clin. Microbiol 16: 463-496. https://doi.org/10.1128/cmr.16.3.463-496.2003.
Vioretti, R., Khairani, A.F., Fauziah, P.N., Hilmanto, D. (2018). An evaluation of soyghurt potential on tumor necrosis factor-? and soluble endoglin levels in preeclampsia maternal serum-induced placental trophoblast cell in vitro. International Food Research Journal 25(4):1397-1402. http://www.ifrj.upm.edu.my/25%20(04)%202018/(10).pdf.
Zolnikova, O.Y., Ivaschkin, K., Bueverova, E., Ivaschkin, V. (2019). Intestinal Microbiota, Nutrients and Probiotics Viewed from the «Gut-Lung» Axis. Voprosy Pitaniia 88(3):13-22. https://doi.org/10.24411/0042-8833-2019-10025.
DOI: https://doi.org/10.14421/biomedich.2026.151.%25p
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Prima Nanda Fauziah, Imas Latifah, Ratna Mutu Manikam, Masdianto Masdianto
Biology, Medicine, & Natural Product Chemistry |
|
